Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
CD56dimCD16dim NK cells are the dominant effector cells against HIV-infected primary T-cells.
Journal: bioRxiv : the preprint server for biology
Published: July 10, 2026
HIV tri-specific killer engagers directly enhance NK cell function and safely expand NK cells in vivo.
Journal: Cell reports. Medicine
Published: November 12, 2025
iPSC-derived NK cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engager.
Journal: Neuro-oncology
Published: October 07, 2025
Engineering B cells to Express Fully Customizable Antibodies with Enhanced Fc Functions.
Journal: Research square
Published: September 18, 2025
Engineering B cells to express fully customizable antibodies with enhanced Fc functions.
Journal: Nature communications
Published: August 26, 2025
Engineering B cells to Express Fully Customizable Antibodies with Enhanced Fc Functions.
Journal: bioRxiv : the preprint server for biology
Published: August 08, 2025
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer.
Journal: Journal for immunotherapy of cancer
Published: July 10, 2025
The transcription factor BCL11B drives NK cell cytotoxicity and antitumor activity.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 14, 2025
Impact of the IL-15 superagonist N-803 on lymphatic reservoirs of HIV.
Journal: JCI insight
Published: January 02, 2025
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma.
Journal: Frontiers in immunology
Published: March 26, 2024
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting.
Journal: Journal for immunotherapy of cancer
Published: November 05, 2023
Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection.
Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection.
Journal: The Journal of infectious diseases
Published: August 05, 2023
Last Updated: 09/26/2026